A phase II trial of temsirolimus and bevacizumab
A phase II trial of temsirolimus and bevacizumab in patients with endometrial, ovarian, hepatocellular carcinoma, carcinoid, or islet cell cancer: Ovarian cancer (OC) subset¿A study of the Princess Margaret, Mayo, Southeast phase II, and California Cancer (CCCP) N01 Consortia NCI#8233. | |
|---|---|
| Sponsor(s) | H. Lee Moffitt Cancer Center and Research Institute |
| Principal Investigator(s) | John Kauh, MD |
| Dates | 10/22/2009 - 9/30/2011 |
